| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $999,997 ) |
| | 2024 | 2024 | INBIOS INTERNATIONAL INC | 307 WESTLAKE AVE N STE 300 | SEATTLE | WA | 98109-5235 | KING | USA | R44AI184032 | Development of Next-gen Chagas DetectTM Plus Rapid test for sensitive and specific diagnosis of Chagas disease | 000 | 1 | NIH | 5/8/2024 | $999,997 |
| | 2024 | 2021 | INBIOS INTERNATIONAL INC | 307 WESTLAKE AVE N STE 300 | SEATTLE | WA | 98109-5235 | KING | USA | R41AI149940 | Point-of-care antigen detection assay for early diagnosis of Ebola virus disease (EVD) | 000 | 2 | NIH | 8/28/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $0 ) |
| | 2023 | 2021 | INBIOS INTERNATIONAL INC | 307 WESTLAKE AVE N STE 300 | SEATTLE | WA | 98109-5235 | KING | USA | R41AI149940 | Point-of-care antigen detection assay for early diagnosis of Ebola virus disease (EVD) | 000 | 2 | NIH | 3/8/2023 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $298,935 ) |
| | 2021 | 2021 | INBIOS INTERNATIONAL INC | 307 WESTLAKE AVE N STE 300 | SEATTLE | WA | 98109-5235 | KING | USA | R41AI149940 | Point-of-care antigen detection assay for early diagnosis of Ebola virus disease (EVD) | 000 | 2 | NIH | 2/19/2021 | $298,935 |
|
| Issue Date FY: 2020 ( Subtotal = $299,112 ) |
| | 2020 | 2020 | INBIOS INTERNATIONAL INC | 307 WESTLAKE AVE N STE 300 | SEATTLE | WA | 98109-5235 | KING | USA | R41AI149940 | Point-of-care antigen detection assay for early diagnosis of Ebola virus disease (EVD) | 000 | 1 | NIH | 3/10/2020 | $299,112 |
| | 2020 | 2016 | INBIOS INTERNATIONAL INC | 307 WESTLAKE AVE N STE 300 | SEATTLE | WA | 98109-5235 | KING | USA | R42AI102482 | Antigen Detection assay for the Diagnosis of Melioidosis | 000 | 5 | NIH | 12/10/2019 | $0 |
|
| Issue Date FY: 2018 ( Subtotal = $0 ) |
| | 2018 | 2016 | INBIOS INTERNATIONAL, INC | 562 1ST AVE S STE 600 | SEATTLE | WA | 98104-3829 | KING | USA | R42AI102482 | Antigen Detection assay for the Diagnosis of Melioidosis | 000 | 5 | NIH | 6/19/2018 | $0 |
|
| Issue Date FY: 2016 ( Subtotal = $700,138 ) |
| | 2016 | 2016 | INBIOS INTERNATIONAL, INC | 562 1ST AVENUE SOUTH SUITE 600 | SEATTLE | WA | 98104-3829 | KING | USA | R42AI102482 | Antigen Detection assay for the Diagnosis of Melioidosis | 000 | 5 | NIH | 6/20/2016 | $700,138 |
|
| Issue Date FY: 2015 ( Subtotal = $673,521 ) |
| | 2015 | 2015 | INBIOS INTERNATIONAL, INC | 562 1ST AVENUE SOUTH SUITE 600 | SEATTLE | WA | 98104-3829 | KING | USA | R42AI102482 | Antigen Detection assay for the Diagnosis of Melioidosis | 000 | 4 | NIH | 6/8/2015 | $673,521 |
|
| Issue Date FY: 2014 ( Subtotal = $621,080 ) |
| | 2014 | 2014 | INBIOS INTERNATIONAL, INC | 562 1ST AVENUE SOUTH SUITE 600 | SEATTLE | WA | 98104-3829 | KING | USA | R42AI102482 | Antigen Detection assay for the Diagnosis of Melioidosis | 000 | 3 | NIH | 7/1/2014 | $621,080 |
|
| Issue Date FY: 2013 ( Subtotal = $299,699 ) |
| | 2013 | 2013 | INBIOS INTERNATIONAL, INC | 562 1ST AVENUE SOUTH SUITE 600 | SEATTLE | WA | 98104-3829 | KING | USA | R41AI102482 | ANTIGEN DETECTION ASSAY FOR THE DIAGNOSIS OF MELIOIDOSIS | 000 | 2 | NIH | 5/24/2013 | $299,699 |
|
| Issue Date FY: 2012 ( Subtotal = $482,129 ) |
| | 2012 | 2012 | INBIOS INTERNATIONAL, INC | 562 1ST AVENUE SOUTH SUITE 600 | SEATTLE | WA | 98104-3829 | KING | USA | R43DK096713 | SENSITIVE AND SPECIFIC RAPID DIAGNOSTIC TEST FOR ACUTE AND CHRONIC PANCREATITIS | 000 | 1 | NIH | 8/28/2012 | $182,430 |
| | 2012 | 2012 | INBIOS INTERNATIONAL, INC | 562 1ST AVENUE SOUTH SUITE 600 | SEATTLE | WA | 98104-3829 | KING | USA | R41AI102482 | ANTIGEN DETECTION ASSAY FOR THE DIAGNOSIS OF MELIOIDOSIS | 000 | 1 | NIH | 6/15/2012 | $299,699 |
| | 2012 | 2012 | INBIOS INTERNATIONAL, INC | 562 1ST AVENUE SOUTH SUITE 600 | SEATTLE | WA | 98104 | KING | USA | R41AI102482 | ANTIGEN DETECTION ASSAY FOR THE DIAGNOSIS OF MELIOIDOSIS | 001 | 1 | NIH | 9/25/2012 | $299,699 |
| | 2012 | 2012 | INBIOS INTERNATIONAL, INC | 562 1ST AVENUE SOUTH SUITE 600 | SEATTLE | WA | 98104 | KING | USA | R41AI102482 | ANTIGEN DETECTION ASSAY FOR THE DIAGNOSIS OF MELIOIDOSIS | 001 | 1 | NIH | 9/25/2012 | -$299,699 |
|
| Issue Date FY: 2010 ( Subtotal = $459,198 ) |
| | 2010 | 2010 | INBIOS INTERNATIONAL, INC | 562 1ST AVENUE SOUTH SUITE 600 | SEATTLE | WA | 98104-3829 | KING | USA | R44AI052683 | GEOGRAPHICALLY ROBUST RAPID ASSAY FOR T. CRUZI INFECTION | 001 | 5 | NIH | 8/20/2010 | $459,198 |
| | 2010 | 2009 | INBIOS INTERNATIONAL, INC | 562 1ST AVENUE SOUTH SUITE 600 | SEATTLE | WA | 98104 | KING | USA | R44AI052683 | GEOGRAPHICALLY ROBUST RAPID ASSAY FOR T. CRUZI INFECTION | 000 | 4 | NIH | 10/19/2009 | $0 |
|
| Issue Date FY: 2009 ( Subtotal = $530,883 ) |
| | 2009 | 2009 | INBIOS INTERNATIONAL, INC | 562 1ST AVENUE SOUTH SUITE 600 | SEATTLE | WA | 98104-3829 | KING | USA | R44AI052683 | GEOGRAPHICALLY ROBUST RAPID ASSAY FOR T. CRUZI INFECTION | 000 | 4 | NIH | 8/24/2009 | $530,883 |
| | 2009 | 2009 | INBIOS INTERNATIONAL, INC | 562 1ST AVENUE SOUTH SUITE 600 | SEATTLE | WA | 98104 | KING | USA | R44AI052683 | GEOGRAPHICALLY ROBUST RAPID ASSAY FOR T. CRUZI INFECTION | 001 | 4 | NIH | 10/19/2009 | $0 |
|
| Issue Date FY: 2008 ( Subtotal = $309,725 ) |
| | 2008 | 2008 | INBIOS INTERNATIONAL, INC | 562 1ST AVENUE SOUTH SUITE 600 | SEATTLE | WA | 98104 | KING | USA | R43AI074172 | RAPID ANTIGEN DETECTION TEST FOR DENGUE INFECTION | 000 | 2 | NIH | 7/31/2008 | $309,725 |
|
| Issue Date FY: 2007 ( Subtotal = $653,837 ) |
| | 2007 | 2007 | INBIOS INTERNATIONAL, INC | 562 1ST AVENUE SOUTH SUITE 600 | SEATTLE | WA | 98104 | KING | USA | R43AI074172 | RAPID ANTIGEN DETECTION TEST FOR DENGUE INFECTION | 000 | 1 | NIH | 8/14/2007 | $375,019 |
| | 2007 | 2007 | INBIOS INTERNATIONAL, INC | 562 1ST AVENUE SOUTH SUITE 600 | SEATTLE | WA | 98104 | KING | USA | R43AI068166 | DEVELOPMENT OF RAPID DETECTION TESTS FOR BRUCELLA SPECIES | 000 | 2 | NIH | 8/28/2007 | $278,818 |
|
| Issue Date FY: 2006 ( Subtotal = $1,226,136 ) |
| | 2006 | 2006 | INBIOS INTERNATIONAL, INC | 562 1ST AVENUE SOUTH SUITE 600 | SEATTLE | WA | 98104 | KING | USA | R41AI068291 | ANTIGEN DETECTION ASSAY FOR TUBERCULOSIS | 000 | 1 | NIH | 9/1/2006 | $386,997 |
| | 2006 | 2006 | INBIOS INTERNATIONAL, INC | 562 1ST AVENUE SOUTH SUITE 600 | SEATTLE | WA | 98104 | KING | USA | R43AI066647 | DEVELOPMENT OF RAPID DETECTION TESTS FOR B PSEUDOMALLEI | 000 | 2 | NIH | 8/10/2006 | $510,135 |
| | 2006 | 2006 | INBIOS INTERNATIONAL, INC | 562 1ST AVENUE SOUTH SUITE 600 | SEATTLE | WA | 98104 | KING | USA | R43AI068166 | DEVELOPMENT OF RAPID DETECTION TESTS FOR BRUCELLA SPECIES | 000 | 1 | NIH | 8/21/2006 | $329,004 |
|
| Issue Date FY: 2005 ( Subtotal = $847,547 ) |
| | 2005 | 2005 | INBIOS INTERNATIONAL, INC | 562 1ST AVENUE SOUTH SUITE 600 | SEATTLE | WA | 98104 | KING | USA | R43AI066647 | DEVELOPMENT OF RAPID DETECTION TESTS FOR B PSEUDOMALLEI | 000 | 1 | NIH | 8/25/2005 | $465,727 |
| | 2005 | 2005 | INBIOS INTERNATIONAL, INC | 562 1ST AVENUE SOUTH SUITE 600 | SEATTLE | WA | 98104 | KING | USA | R44AI052683 | GEOGRAPHICALLY ROBUST RAPID ASSAY FOR T. CRUZI INFECTION | 000 | 3 | NIH | 8/5/2005 | $381,820 |
|
| Issue Date FY: 2004 ( Subtotal = $470,363 ) |
| | 2004 | 2004 | INBIOS INTERNATIONAL, INC | 562 1ST AVENUE SOUTH SUITE 600 | SEATTLE | WA | 98104 | KING | USA | R44AI052683 | GEOGRAPHICALLY ROBUST RAPID ASSAY FOR T. CRUZI INFECTION | 000 | 2 | NIH | 6/21/2004 | $470,363 |
|
| Issue Date FY: 2002 ( Subtotal = $446,781 ) |
| | 2002 | 2002 | INBIOS INTERNATIONAL, INC | 562 1ST AVENUE SOUTH SUITE 600 | SEATTLE | WA | 98104 | KING | USA | R43AI052683 | A NOVEL, RAPID TEST FOR DIAGNOSIS OF T.CRUZI INFECTION | 000 | 1 | NIH | 7/29/2002 | $99,812 |
| | 2002 | 2002 | INBIOS INTERNATIONAL, INC | 562 1ST AVENUE SOUTH SUITE 600 | SEATTLE | WA | 98104 | KING | USA | R44AI047551 | NEW GENERATION TEST FOR VISCERAL LEISHMANIASIS DIAGNOSIS | 000 | 3 | NIH | 8/19/2002 | $346,969 |
|
| Issue Date FY: 2001 ( Subtotal = $391,863 ) |
| | 2001 | 2001 | INBIOS INTERNATIONAL, INC | 562 1ST AVENUE SOUTH SUITE 600 | SEATTLE | WA | 98104 | KING | USA | R44AI047551 | NEW GENERATION TEST FOR VISCERAL LEISHMANIASIS DIAGNOSIS | 000 | 2 | NIH | 9/3/2001 | $391,863 |
|
|
